Nama's AI scorecard currently rates Aveanna Healthcare Hold (5.3 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is AVAH's P/E ratio?

Aveanna Healthcare trades at a trailing price-to-earnings ratio of 18.4.

When does AVAH report earnings?

Aveanna Healthcare's next scheduled report is on Nov 12, 2026. Analysts expect EPS of $0.21.

What is the AVAH price target?

The median analyst price target from 10 analysts is $15.00, with a range of $13.00 – $16.00.

Is AVAH Shariah compliant?

Nama's AAOIFI-style screen reads Aveanna Healthcare as Not Shariah Compliant. At least one of the three ratios or the industry test failed.

Nama Insights

Aveanna Healthcare (AVAH)

Healthcare · Medical Care Facilities · NASDAQ

Aveanna Healthcare (AVAH) is a Healthcare company in the Medical Care Facilities industry. It has a market capitalization of $2.89B, a trailing price-to-earnings ratio of 18.4 and a free-cash-flow yield of 4.2%. Over the most recent reported fiscal year, revenue grew 20.2% and free cash flow per share grew 303.7%. Nama's AI scorecard rates it Hold, 5.3 out of 10. On 12-month momentum it ranks in the rising band of its market.

AI scorecard

Hold · 5.3/10

The sections balance. As of Nov 7, 2026.

Momentum

Rising · +42.6% over 12 months ex. last

Second-best fifth of its market on the past year's move.

Shariah screen

Not Shariah Compliant

At least one of the three ratios or the industry test failed.

Off its high

-9.9%

How far the last close sits under the highest price of the past five years.

Market cap	$2.89B
Trailing P/E	18.4
Price / book	10.0
Price / sales	1.1
FCF yield	4.2%
Dividend yield	—
Gross margin	32.3%
Operating margin	10.8%
Net margin	10.6%
Revenue growth (YoY)	+20.2%
Revenue growth (3-yr annual)	+10.8%
EPS growth (YoY)	+1100.0%
FCF/share growth (YoY)	+303.7%
Beta	1.9
Exchange	NASDAQ
Sector	Healthcare
Industry	Medical Care Facilities

AVAH earnings

Next report: Nov 12, 2026 (Q3 2026, EPS estimate $0.21). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q2 2026	Aug 13, 2026	$0.22	$0.17	+29.4%	$670.48M
Q1 2026	May 14, 2026	$0.18	$0.13	+38.5%	$647.91M
Q4 2025	Mar 19, 2026	$0.17	$0.16	+6.2%	$662.48M
Q3 2025	Nov 6, 2025	$0.15	$0.13	+15.4%	$621.94M

AVAH analyst price target

Median target $15.00 from 10 analysts, ranging $13.00 – $16.00.

Medical Care Facilities peers

Ticker	Company	Market cap	P/E
HCA	HCA Healthcare	$103.40B	16.5
THC	Tenet Healthcare	$22.55B	12.7
EHC	Encompass Health	$13.50B	22.4
FMS	Fresenius Medical Care	$12.15B	10.2
DVA	DaVita	$12.04B	13.6
UHS	Universal Health Services	$11.52B	8.6
ENSG	Ensign Group	$10.56B	23.8
PACS	PACS Group	$7.87B	20.1

Explore live AVAH data on Nama Insights →

AVAH FAQ

Is AVAH a buy?: Nama's AI scorecard currently rates Aveanna Healthcare Hold (5.3 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is AVAH's P/E ratio?: Aveanna Healthcare trades at a trailing price-to-earnings ratio of 18.4.
When does AVAH report earnings?: Aveanna Healthcare's next scheduled report is on Nov 12, 2026. Analysts expect EPS of $0.21.
What is the AVAH price target?: The median analyst price target from 10 analysts is $15.00, with a range of $13.00 – $16.00.
Is AVAH Shariah compliant?: Nama's AAOIFI-style screen reads Aveanna Healthcare as Not Shariah Compliant. At least one of the three ratios or the industry test failed.